China Universal Asset Management Company’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Sell
9,911
-969
-9% -$63.1K 0.06% 202
2026
Q1
$517K Buy
10,880
+916
+9% +$41.1K 0.04% 255
2025
Q4
$316K Sell
9,964
-616
-6% -$19.2K 0.02% 298
2025
Q3
$298K Sell
10,580
-1,454
-12% -$44K 0.02% 294
2025
Q2
$443K Buy
12,034
+69
+0.6% +$2.38K 0.04% 246
2025
Q1
$470K Sell
11,965
-621
-5% -$28K 0.04% 249
2024
Q4
$585K Buy
12,586
+1,318
+12% +$59.6K 0.05% 232
2024
Q3
$509K Buy
11,268
+4,427
+65% +$211K 0.06% 215
2024
Q2
$337K Sell
6,841
-4,260
-38% -$174K 0.05% 179
2024
Q1
$381K Buy
11,101
+4,427
+66% +$160K 0.05% 209
2023
Q4
$246K Buy
6,674
+5,204
+354% +$120K 0.05% 188
2023
Q3
$29.8K Buy
1,470
+721
+96% +$15.8K 0.01% 269
2023
Q2
$15.3K Sell
749
-21
-3% -$315 ﹤0.01% 289
2023
Q1
$11.6K Buy
770
+196
+34% +$4.33K ﹤0.01% 273
2022
Q4
$13.7K Buy
574
+46
+9% +$1.33K 0.01% 206
2022
Q3
$19K Buy
+528
New +$22.4K 0.01% 160

Other funds holding TWST

China Universal Asset Management Company's TWST Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Twist Bioscience (TWST) stake by 8.9% in Q2 2026, selling an estimated $63.1K and leaving 9,911 shares worth $1.02M. The position accounts for 0.06% of the portfolio, ranked #202.

China Universal Asset Management Company first reported a position in TWST in Q3 2022 and has held it in 16 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • China Universal Asset Management Company held 9,911 shares of Twist Bioscience worth $1.02M as of Q2 2026.
  • China Universal Asset Management Company sold 969 Twist Bioscience shares in Q2 2026, an estimated $63.1K.
  • Twist Bioscience made up 0.06% of China Universal Asset Management Company's portfolio in Q2 2026, its #202 holding.
  • China Universal Asset Management Company first reported a position in Twist Bioscience in Q3 2022 and has held it in 16 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.